Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Federal Trade Commission
US Department of Justice
Express Scripts
Harvard Business School
Cantor Fitzgerald
Daiichi Sankyo

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017453

« Back to Dashboard

NDA 017453 describes PROGLYCEM, which is a drug marketed by Teva Branded Pharm and is included in two NDAs. It is available from one supplier. Additional details are available on the PROGLYCEM profile page.

The generic ingredient in PROGLYCEM is diazoxide. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the diazoxide profile page.

Summary for 017453

Therapeutic Class:Blood Glucose Regulators
Formulation / Manufacturing:see details

Medical Subject Heading (MeSH) Categories for 017453

Suppliers and Packaging for NDA: 017453

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PROGLYCEM diazoxide SUSPENSION;ORAL 017453 NDA Teva Branded Pharmaceutical Products R&D, Inc. 0575-6200 0575-6200-30 1 BOTTLE, DROPPER in 1 BOX (0575-6200-30) > 30 mL in 1 BOTTLE, DROPPER

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;ORALStrength50MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Farmers Insurance
Harvard Business School
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: